Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion. | Cell Death Dis | 2022 | 35042862 | PubTator, text mining | PubMed |
| SLCO4A1-AS1 promotes colorectal tumourigenesis by regulating Cdk2/c-Myc signalling. | J Biomed Sci | 2022 | 35039060 | PubTator, text mining | PubMed |
| Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. | Mol Cancer | 2022 | 35039054 | PubTator, text mining | PubMed |
| METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination. | Mol Ther Nucleic Acids | 2022 | 35036065 | PubTator, text mining | PubMed |
Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis. | Bioengineered | 2022 | 35034547 | PubTator, text mining | PubMed |
| ALKBH5-mediated N6-methyladenosine modification of TRERNA1 promotes DLBCL proliferation via p21 downregulation. | Cell Death Discov | 2022 | 35031597 | PubTator, text mining | PubMed |
| Long noncoding RNA ADIRF antisense RNA 1 upregulates insulin receptor substrate 1 to decrease the aggressiveness of osteosarcoma by sponging microRNA-761. | Bioengineered | 2022 | 35030964 | PubTator, text mining | PubMed |
| The relation between NEAT1 expression level and survival rate in patients with oral squamous cell carcinoma. | J Dent Sci | 2022 | 35028059 | PubTator, text mining | PubMed |
| Hypoxic Breast Cancer Cell-Derived Exosomal SNHG1 Promotes Breast Cancer Growth and Angiogenesis via Regulating miR-216b-5p/JAK2 Axis. | Cancer Manag Res | 2022 | 35027847 | PubTator, text mining | PubMed |
| Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes. | Sci Rep | 2022 | 35027621 | PubTator, text mining | PubMed |
| The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma. | Mol Ther Oncolytics | 2022 | 35024439 | PubTator, text mining | PubMed |
| Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers. | Mol Ther Oncolytics | 2022 | 35024437 | PubTator, text mining | PubMed |
| LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating m6A modification of miR-375 by METTL14 through DNA methylation. | Cancer Gene Ther | 2022 | 35022519 | PubTator, text mining | PubMed |
| Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression. | Transl Oncol | 2022 | 35021150 | PubTator, text mining | PubMed |
| Elevated lncRNA-UCA1 upregulates EZH2 to promote inflammatory response in sepsis-induced pneumonia via inhibiting HOXA1. | Carcinogenesis | 2022 | 35018436 | PubTator, text mining | PubMed |
| lncRNA HITT inhibits metastasis by attenuating Rab5-mediated endocytosis in lung adenocarcinoma. | Mol Ther | 2022 | 35017116 | PubTator, text mining | PubMed |
| Detection and analysis of long noncoding RNA expression profiles related to epithelial-mesenchymal transition in keloids. | Biomed Eng Online | 2022 | 35012558 | PubTator, text mining | PubMed |
| LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma. | Int J Biol Sci | 2022 | 35002507 | PubTator, text mining | PubMed |
| The LMCD1-AS1/miR-526b-3p/OSBPL5 axis promotes cell proliferation, migration and invasion in non-small cell lung cancer. | BMC Pulm Med | 2022 | 35000595 | PubTator, text mining | PubMed |
| gGATLDA: lncRNA-disease association prediction based on graph-level graph attention network. | BMC Bioinformatics | 2022 | 34983363 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=53